Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBasic Science Investigations

Initial Preclinical Evaluation of 18F-Fluorodeoxysorbitol PET as a Novel Functional Renal Imaging Agent

Hiroshi Wakabayashi, Rudolf A. Werner, Nobuyuki Hayakawa, Mehrbod S. Javadi, Chen Xinyu, Ken Herrmann, Steven P. Rowe, Constantin Lapa and Takahiro Higuchi
Journal of Nuclear Medicine October 2016, 57 (10) 1625-1628; DOI: https://doi.org/10.2967/jnumed.116.172718
Hiroshi Wakabayashi
1Department of Nuclear Medicine, University of Würzburg, Würzburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rudolf A. Werner
1Department of Nuclear Medicine, University of Würzburg, Würzburg, Germany
2Comprehensive Heart Failure Center, University of Würzburg, Würzburg, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nobuyuki Hayakawa
1Department of Nuclear Medicine, University of Würzburg, Würzburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mehrbod S. Javadi
3Division of Nuclear Medicine and Molecular Imaging, The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chen Xinyu
1Department of Nuclear Medicine, University of Würzburg, Würzburg, Germany
2Comprehensive Heart Failure Center, University of Würzburg, Würzburg, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ken Herrmann
1Department of Nuclear Medicine, University of Würzburg, Würzburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven P. Rowe
3Division of Nuclear Medicine and Molecular Imaging, The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Constantin Lapa
1Department of Nuclear Medicine, University of Würzburg, Würzburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takahiro Higuchi
1Department of Nuclear Medicine, University of Würzburg, Würzburg, Germany
2Comprehensive Heart Failure Center, University of Würzburg, Würzburg, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Results of in vivo 18F-FDS PET imaging. (A) Whole-body dynamic PET images in coronal view. High tracer secretion exclusively via kidneys and time-dependent increase of bladder activity are seen. (B) Dynamic right kidney images of transverse and coronal views. Rapid tracer accumulation in renal cortex and tracer transit into collecting system can be observed. (C) Examples of time–activity curves of kidneys (left) and bladder (right) assessed by dynamic PET imaging. %ID/cm3 = percentage injected dose per centimeter cubed.

Tables

  • Figures
    • View popup
    TABLE 1

    Postmortem Tissue Counting in Rats at 10 Minutes, 30 Minutes, and 1 Hour After Injection of 18F-FDS and 99mTc-DTPA

    18F-FDS99mTc-DTPA
    Organ10 min30 min1 h10 min30 min1 h
    Blood0.61 ± 0.160.38 ± 0.03*0.15 ± 0.01*0.84 ± 0.180.34 ± 0.030.09 ± 0.02
    Liver0.54 ± 0.10*0.31 ± 0.03*0.11 ± 0.01†0.34 ± 0.090.15 ± 0.010.05 ± 0.01
    Kidneys1.77 ± 0.741.21 ± 0.09*0.53 ± 0.212.51 ± 0.971.50 ± 0.180.77 ± 0.27
    Intestine0.17 ± 0.050.15 ± 0.02*0.10 ± 0.01†0.14 ± 0.030.08 ± 0.030.04 ± 0.01
    Muscle0.14 ± 0.04*0.13 ± 0.030.05 ± 0.01*0.20 ± 0.040.16 ± 0.040.02 ± 0.01
    Spleen0.18 ± 0.050.22 ± 0.01†0.12 ± 0.010.16 ± 0.030.11 ± 0.010.10 ± 0.17
    Stomach0.08 ± 0.020.12 ± 0.060.03 ± 0.010.11 ± 0.030.12 ± 0.060.02 ± 0.01
    Bone0.14 ± 0.040.08 ± 0.010.05 ± 0.01†0.15 ± 0.040.07 ± 0.020.02 ± 0.01
    Heart0.26 ± 0.070.21 ± 0.01*0.13 ± 0.01*0.30 ± 0.070.14 ± 0.010.05 ± 0.03
    Lung0.47 ± 0.160.34 ± 0.060.17 ± 0.02*0.63 ± 0.240.31 ± 0.070.09 ± 0.06
    • ↵* P < 0.05 vs. 99mTc-DTPA.

    • ↵† P < 0.0001 vs. 99mTc-DTPA.

    • Data are %ID/g (mean value ± SD). Number of rats was 5 at 10 min, 4 at 30 min, and 5 at 1 h after tracer injection.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 57 (10)
Journal of Nuclear Medicine
Vol. 57, Issue 10
October 1, 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Initial Preclinical Evaluation of 18F-Fluorodeoxysorbitol PET as a Novel Functional Renal Imaging Agent
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Initial Preclinical Evaluation of 18F-Fluorodeoxysorbitol PET as a Novel Functional Renal Imaging Agent
Hiroshi Wakabayashi, Rudolf A. Werner, Nobuyuki Hayakawa, Mehrbod S. Javadi, Chen Xinyu, Ken Herrmann, Steven P. Rowe, Constantin Lapa, Takahiro Higuchi
Journal of Nuclear Medicine Oct 2016, 57 (10) 1625-1628; DOI: 10.2967/jnumed.116.172718

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Initial Preclinical Evaluation of 18F-Fluorodeoxysorbitol PET as a Novel Functional Renal Imaging Agent
Hiroshi Wakabayashi, Rudolf A. Werner, Nobuyuki Hayakawa, Mehrbod S. Javadi, Chen Xinyu, Ken Herrmann, Steven P. Rowe, Constantin Lapa, Takahiro Higuchi
Journal of Nuclear Medicine Oct 2016, 57 (10) 1625-1628; DOI: 10.2967/jnumed.116.172718
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • PET Measurement of Renal Glomerular Filtration Rate: Is There a Role in Nuclear Medicine?
  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • 11C-PABA as a PET Radiotracer for Functional Renal Imaging: Preclinical and First-in-Human Study
  • Functional Renal Imaging with 2-Deoxy-2-18F-Fluorosorbitol PET in Rat Models of Renal Disorders
  • A Systematic Approach for Developing Bacteria-Specific Imaging Tracers
  • PET Measurement of Renal Glomerular Filtration Rate: Is There a Role in Nuclear Medicine?
  • Google Scholar

More in this TOC Section

  • 11C-Methionine PET of Myocardial Inflammation in a Rat Model of Experimental Autoimmune Myocarditis
  • Counting Rate Characteristics and Image Distortion in Preclinical PET Imaging During Radiopharmaceutical Therapy
  • Design and Fabrication of Kidney Phantoms for Internal Radiation Dosimetry Using 3D Printing Technology
Show more Basic Science Investigations

Similar Articles

Keywords

  • renography
  • PET
  • 18F-FDS
  • 99mTc-DTPA
  • rat
SNMMI

© 2025 SNMMI

Powered by HighWire